BIO
Price
$234.75
Change
-$10.77 (-4.39%)
Updated
Apr 3 closing price
Capitalization
9.79B
20 days until earnings call
QDEL
Price
$32.49
Change
-$2.14 (-6.18%)
Updated
Apr 3 closing price
Capitalization
3.14B
26 days until earnings call
Ad is loading...

BIO vs QDEL

Header iconBIO vs QDEL Comparison
Open Charts BIO vs QDELBanner chart's image
Bio-Rad Laboratories
Price$234.75
Change-$10.77 (-4.39%)
Volume$364.84K
Capitalization9.79B
QuidelOrtho
Price$32.49
Change-$2.14 (-6.18%)
Volume$1.52M
Capitalization3.14B
BIO vs QDEL Comparison Chart
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. QDEL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a StrongBuy and QDEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BIO: $234.75 vs. QDEL: $32.49)
Brand notoriety: BIO and QDEL are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIO: 107% vs. QDEL: 178%
Market capitalization -- BIO: $9.79B vs. QDEL: $3.14B
BIO [@Medical Specialties] is valued at $9.79B. QDEL’s [@Medical Specialties] market capitalization is $3.14B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileQDEL’s FA Score has 1 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • QDEL’s FA Score: 1 green, 4 red.
According to our system of comparison, QDEL is a better buy in the long-term than BIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while QDEL’s TA Score has 4 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 4 bearish.
  • QDEL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BIO is a better buy in the short-term than QDEL.

Price Growth

BIO (@Medical Specialties) experienced а -5.02% price change this week, while QDEL (@Medical Specialties) price change was -9.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.68%. For the same industry, the average monthly price growth was +1.30%, and the average quarterly price growth was +1.15%.

Reported Earning Dates

BIO is expected to report earnings on Apr 24, 2025.

QDEL is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-4.68% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($9.79B) has a higher market cap than QDEL($3.14B). QDEL has higher P/E ratio than BIO: QDEL (9.76) vs BIO (3.64). QDEL YTD gains are higher at: -27.071 vs. BIO (-28.541). QDEL has higher annual earnings (EBITDA): 607M vs. BIO (-654.76M). BIO has more cash in the bank: 1.61B vs. QDEL (167M). BIO has less debt than QDEL: BIO (1.41B) vs QDEL (2.61B). QDEL has higher revenues than BIO: QDEL (3B) vs BIO (2.67B).
BIOQDELBIO / QDEL
Capitalization9.79B3.14B312%
EBITDA-654.76M607M-108%
Gain YTD-28.541-27.071105%
P/E Ratio3.649.7637%
Revenue2.67B3B89%
Total Cash1.61B167M962%
Total Debt1.41B2.61B54%
FUNDAMENTALS RATINGS
BIO vs QDEL: Fundamental Ratings
BIO
QDEL
OUTLOOK RATING
1..100
207
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
6482
P/E GROWTH RATING
1..100
7712
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QDEL's Valuation (57) in the Medical Specialties industry is in the same range as BIO (80). This means that QDEL’s stock grew similarly to BIO’s over the last 12 months.

QDEL's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BIO (100). This means that QDEL’s stock grew similarly to BIO’s over the last 12 months.

BIO's SMR Rating (95) in the Medical Specialties industry is in the same range as QDEL (97). This means that BIO’s stock grew similarly to QDEL’s over the last 12 months.

BIO's Price Growth Rating (64) in the Medical Specialties industry is in the same range as QDEL (82). This means that BIO’s stock grew similarly to QDEL’s over the last 12 months.

QDEL's P/E Growth Rating (12) in the Medical Specialties industry is somewhat better than the same rating for BIO (77). This means that QDEL’s stock grew somewhat faster than BIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOQDEL
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 14 days ago
69%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 9 days ago
65%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QDEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BAR30.64-0.19
-0.62%
GraniteShares Gold Trust
JPIN56.69-0.69
-1.20%
JPMorgan Diversified Return Intl Eq ETF
XB38.51-0.48
-1.24%
BondBloxx B Rated USD Hi Yld Corp Bd ETF
ACVF41.51-1.73
-4.00%
American Conservative Values ETF
XLC92.53-4.32
-4.46%
The Comm Svcs Sel Sect SPDR® ETF

BIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIO has been loosely correlated with A. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BIO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIO
1D Price
Change %
BIO100%
-4.39%
A - BIO
56%
Loosely correlated
-5.45%
TMO - BIO
56%
Loosely correlated
-3.89%
RVTY - BIO
55%
Loosely correlated
-5.59%
RGEN - BIO
54%
Loosely correlated
-7.04%
DHR - BIO
52%
Loosely correlated
-3.54%
More